Access AccuTnl+3 troponin I assay regulatory update

Danaher's Beckman Coulter Inc. subsidiary said FDA granted 510(k) clearance for its Access AccuTnl+3 troponin I assay for use on its Access 2 immunoassay system to determine levels of cardiac troponi...